Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528381 | 12552838 | 1 | I | 20160207 | 0 | 20160712 | 20160712 | DIR | 83.00 | YR | F | N | 76.00000 | KG | 20160711 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528381 | 12552838 | 1 | PS | DOCUSATE | DOCUSATE | 1 | Oral | D | D | 0 | 100 | MG | BID | ||||||
| 125528381 | 12552838 | 2 | C | CHLORHEXIDINE | CHLORHEXIDINE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 6 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 10 | C | HEPARIN | HEPARIN SODIUM | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 12 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 14 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 16 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 18 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 20 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 22 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 24 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 26 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 28 | C | NICARDIPINE | NICARDIPINE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 30 | C | PROPOFOL. | PROPOFOL | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 32 | C | NACL | SODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 34 | C | ALBUMIN | ALBUMIN HUMAN | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 36 | C | ETOMIDATE. | ETOMIDATE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 38 | C | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | 0 | ||||||||||||
| 125528381 | 12552838 | 40 | C | DEXTROSE. | DEXTROSE | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125528381 | 12552838 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125528381 | 12552838 | Burkholderia test positive | |
| 125528381 | 12552838 | General physical health deterioration | |
| 125528381 | 12552838 | Hypotension | |
| 125528381 | 12552838 | Ischaemic hepatitis | |
| 125528381 | 12552838 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125528381 | 12552838 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125528381 | 12552838 | 1 | 20160202 | 20160207 | 0 |